Leveraging deep sequencing, high-sensitivity proteomics, and transcriptomic profiling, we identified TET2 mutations as a key driver of LDLR up-regulation, heightened lipid accumulation, and inflammasome activation in macrophages—mechanisms that promote CAD complexity and mortality. The gene discussed is LDLR; the disease is coronary artery disorder.